- Companies
- Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Valuation Multiples
Tatva Chintan Pharma Chem is valued at $465M as of October 2026, a 7.6x revenue multiple. In the last 12 months, Tatva Chintan Pharma Chem revenue was $63M and Tatva Chintan Pharma Chem EBITDA was $13M.
Tatva Chintan Pharma Chem Overview
About Tatva Chintan Pharma Chem
Tatva Chintan makes specialty chemicals such as structure directing agents, phase transfer catalysts and electrolyte salts for pharma, agro and battery customers. It is based in Vadodara.
Founded
1996
HQ
Employees
1.1K
Website
Sectors
Financials (LTM)
EV
$481M
Valuation Multiples
Start free trialTatva Chintan Pharma Chem Financials
Tatva Chintan Pharma Chem reported last 12-month revenue of $63M and EBITDA of $13M.
In the same LTM period, Tatva Chintan Pharma Chem generated $35M in gross profit, $13M in EBITDA, and $6M in net income.
Tatva Chintan Pharma Chem P&L
In the most recent fiscal year, Tatva Chintan Pharma Chem reported revenue of $53M and EBITDA of $10M.
Tatva Chintan Pharma Chem is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 19%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
Tatva Chintan Pharma Chem Stock Performance
Tatva Chintan Pharma Chem has current market cap of $465M, and enterprise value of $481M.
Tatva Chintan Pharma Chem's stock price is $19.88.
Tatva Chintan Pharma Chem share price increased by 7.0% in the last 30 days, and by 24.7% in the last year.
Tatva Chintan Pharma Chem has an EPS (earnings per share) of $0.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $481M | $465M | -0.7% | 7.0% | 6.7% | 24.7% | $0.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTatva Chintan Pharma Chem Valuation Multiples
Tatva Chintan Pharma Chem trades at 7.6x EV/Revenue multiple, and 37.6x EV/EBITDA.
Tatva Chintan Pharma Chem Financial Valuation Multiples
As of October 22, 2026, Tatva Chintan Pharma Chem has market cap of $465M and EV of $481M.
Tatva Chintan Pharma Chem has a P/E ratio of 74.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tatva Chintan Pharma Chem Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Tatva Chintan Pharma Chem Margins & Growth Rates
Tatva Chintan Pharma Chem grew revenue by 35% and EBITDA by 51% in the last fiscal year.
In the most recent fiscal year, Tatva Chintan Pharma Chem reported gross margin of 53%, EBITDA margin of 19%, and net margin of 8%.
Tatva Chintan Pharma Chem Margins
Tatva Chintan Pharma Chem Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Tatva Chintan Pharma Chem Operational KPIs
Tatva Chintan Pharma Chem's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Tatva Chintan Pharma Chem's Rule of 40 is 56% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Tatva Chintan Pharma Chem's Rule of X is 108% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Tatva Chintan Pharma Chem Competitors
Tatva Chintan Pharma Chem competitors include Filatex India, Grupa Azoty, Creta Plastics, Laxmi Organic Indus, Alujain, Foseco India, Ellenbarrie Industrial, Uflex, Gujarat Themis Biosyn and Prasol Chemicals.
Most Tatva Chintan Pharma Chem public comparables operate across Chemicals.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $439M | $34M | 1.0x | - | 13.5x | - | |||
| $3.4B | ($841M) | 0.9x | 0.9x | (3.7x) | 12.4x | |||
| $441M | $70M | 0.8x | - | 4.9x | - | |||
| $293M | $20M | 1.8x | 1.1x | 26.5x | 11.9x | |||
| $347M | ($296M) | 2.1x | 1.6x | (2.5x) | 7.4x | |||
| $68M | $11M | 6.5x | - | 40.5x | - | |||
| $34M | $11M | 14.3x | 10.6x | 43.3x | 30.8x | |||
| $1.6B | $193M | 0.9x | - | 7.4x | - | |||
This data is available for Pro users. Sign up to see all Tatva Chintan Pharma Chem competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tatva Chintan Pharma Chem
| When was Tatva Chintan Pharma Chem founded? | Tatva Chintan Pharma Chem was founded in 1996. |
| Where is Tatva Chintan Pharma Chem headquartered? | Tatva Chintan Pharma Chem is headquartered in India. |
| How many employees does Tatva Chintan Pharma Chem have? | As of today, Tatva Chintan Pharma Chem has over 1K employees. |
| Is Tatva Chintan Pharma Chem publicly listed? | Yes, Tatva Chintan Pharma Chem is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem trades under 543321 ticker. |
| When did Tatva Chintan Pharma Chem go public? | Tatva Chintan Pharma Chem went public in 2021. |
| Who are competitors of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem main competitors include Filatex India, Grupa Azoty, Creta Plastics, Laxmi Organic Indus, Alujain, Foseco India, Ellenbarrie Industrial, Uflex, Gujarat Themis Biosyn, Prasol Chemicals. |
| What is the current market cap of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem's current market cap is $465M. |
| What is the current revenue of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem's last 12 months revenue is $63M. |
| What is the current revenue growth of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem revenue growth (NTM/LTM) is 27%. |
| What is the current EV/Revenue multiple of Tatva Chintan Pharma Chem? | Current revenue multiple of Tatva Chintan Pharma Chem is 7.6x. |
| What is the current EBITDA of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem's last 12 months EBITDA is $13M. |
| What is Tatva Chintan Pharma Chem's EBITDA margin? | Tatva Chintan Pharma Chem's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Tatva Chintan Pharma Chem? | Current EBITDA multiple of Tatva Chintan Pharma Chem is 37.6x. |
| What is the current FCF of Tatva Chintan Pharma Chem? | Tatva Chintan Pharma Chem's last 12 months FCF is ($6M). |
| What is Tatva Chintan Pharma Chem's FCF margin? | Tatva Chintan Pharma Chem's last 12 months FCF margin is (10%). |
| What is the current EV/FCF multiple of Tatva Chintan Pharma Chem? | Current FCF multiple of Tatva Chintan Pharma Chem is (74.1x). |
| How many companies Tatva Chintan Pharma Chem has acquired to date? | Tatva Chintan Pharma Chem hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Tatva Chintan Pharma Chem has invested to date? | Tatva Chintan Pharma Chem hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Tatva Chintan Pharma Chem
Lists including Tatva Chintan Pharma Chem
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




